Total Revenues (USD, millions)

Operation and Maintenance Expense (USD, millions)

Depreciation and Amortization Expense (USD, millions)

Franchise Fees and Other Taxes (USD, millions)

Other Income, Net (USD, millions)

Interest Income (USD, millions)

Interest Expense (USD, millions)

Income before Income Taxes and Equity Earnings (USD, millions)

Income Tax Benefit (Expense) (USD, millions)

Equity Earnings (USD, millions)

Net Income (USD, millions)

Earnings Attributable to Noncontrolling Interests (USD, millions)

Preferred Dividends (USD, millions)

Preferred Dividends of Subsidiary (USD, millions)

Earnings Attributable to Common Shares (USD, millions)

057a36752070c2cbef5a8b5737cb4da291dbcc91a4a8faa890ab020de3768692

Net income (USD, millions)

Depreciation and amortization (USD, millions)

Deferred income taxes and investment tax credits (USD, millions)

Equity earnings (USD, millions)

Share-based compensation expense (USD, millions)

Fixed-price contracts and other derivatives (USD, millions)

Bad debt expense (USD, millions)

Other adjustments to net income (USD, millions)

Net change in working capital components (USD, millions)

Distributions from investments (USD, millions)

Changes in other noncurrent assets and liabilities, net (USD, millions)

Net cash provided by operating activities (USD, millions)

Expenditures for property, plant and equipment (USD, millions)

Expenditures for investments (USD, millions)

Purchases of nuclear decommissioning and other trust assets (USD, millions)

Proceeds from sales of nuclear decommissioning and other trust assets (USD, millions)

Other investing cash flows (USD, millions)

Net cash used in investing activities (USD, millions)

Common dividends paid (USD, millions)

Preferred dividends paid (USD, millions)

Issuances of common stock (USD, millions)

Repurchases of common stock (USD, millions)

Issuances of debt (maturities greater than 90 days) (USD, millions)

Payments on debt (maturities greater than 90 days) and finance leases (USD, millions)

(Decrease) increase in short-term debt, net (USD, millions)

Advances from unconsolidated affiliates (USD, millions)

Proceeds from sales of noncontrolling interests, net (USD, millions)

Distributions to noncontrolling interests (USD, millions)

Contributions from noncontrolling interests (USD, millions)

Settlement of cross-currency swaps (USD, millions)

Other financing cash flows (USD, millions)

Net cash provided by financing activities (USD, millions)

Effect of exchange rate changes on cash, cash equivalents and restricted cash (USD, millions)

Increase in cash, cash equivalents and restricted cash (USD, millions)

Interest payments, net of amounts capitalized (USD, millions)

Income tax payments, net of refunds (USD, millions)

Increase in finance lease obligations for investment in PP&E (USD, millions)

Decrease in ARO for investment in PP&E (USD, millions)

Cash, cash equivalents and restricted cash, January 1 (USD, millions)

Cash, cash equivalents and restricted cash, September 30 (USD, millions)

Cash, cash equivalents and restricted cash, June 30 (USD, millions)

Accrued capital expenditures (USD, millions)

e0ad9766d8cbf048a674503d3f992fa06533a3883a8e355341b939b51ea78478

9489c2e696f6a6d13607358110e0c6a3d55e4dbb4e9711c2a1c2db817c76f900

Adjustments for Non-Cash Items [USD, Millions]

Stock-Based Compensation [USD, Millions]

Changes in Working Capital [USD, Millions]

Capital Expenditures (CapEx) [USD, Millions]

Proceeds from / Repayments of Debt [USD, Millions]

Share Repurchases [USD, Millions]

Dividend Payments [USD, Millions]

Net Change in Cash [USD, Millions]

cd4951c9323c547a7fd229e26d87e65c1f98b8b1885fedfda0551e4f7171348b

Current Assets [USD, Millions]

Cash and Cash Equivalents [USD, Millions]

Accounts Receivable [USD, Millions]

Inventory [USD, Millions]

Non-Current Assets [USD, Millions]

PP&E [USD, Millions]

Goodwill [USD, Millions]

Intangible Assets [USD, Millions]

Current Liabilities [USD, Millions]

Accounts Payable [USD, Millions]

Short-term Debt [USD, Millions]

Accrued Expenses [USD, Millions]

Non-Current Liabilities [USD, Millions]

Long-term Debt [USD, Millions]

Lease Liabilities [USD, Millions]

Deferred Tax Liabilities [USD, Millions]

Shareholders' Equity [USD, Millions]

Retained Earnings [USD, Millions]

Common Stock [USD, Millions]

Additional Paid-in Capital [USD, Millions]

221dd1b0655750559d00adff86ade6d06676dbb0ced3876083c7dfc08f4cb682

Total Revenue [USD, Millions]

Cost of Goods Sold (COGS) [USD, Millions]

SG&A [USD, Millions]

R&D [USD, Millions]

D&A [USD, Millions]

Interest Expense [USD, Millions]

Operating Income (EBIT) [USD, Millions]

Net Income [USD, Millions]

EPS - Basic [USD, Per Share]

EPS - Diluted [USD, Per Share]

052b73570dab21782af8f70f7a0af4fea58f891fa29228f8f30bb58b96505af1

Change in fair value from a hypothetical 10% change in commodity prices for Sempra commodity-based derivatives (USD millions)

SEMPRA (SRE)

Financials